Drug Information
Drug (ID: DG00365) and It's Reported Resistant Information
Name |
Desethylamodiaquine
|
||||
---|---|---|---|---|---|
Synonyms |
Desethylamodiaquine; Monodesethylamodiaquine; 79352-78-6; N-DESETHYL AMODIAQUINE; UNII-BY36SG7NP9; BY36SG7NP9; CHEMBL1235; 4-[(7-chloroquinolin-4-yl)amino]-2-(ethylaminomethyl)phenol; N-MONODESETHYLAMODIAQUINE (DEAQ); 4-((7-Chloroquinolin-4-yl)amino)-2-((ethylamino)methyl)phenol; N-Desethyl amodiaquine diHCl; N-desethylamodiaquine; bidesethylamodiaquine; 4-((7-Chloro-4-quinolinyl)amino)-2-((ethylamino)methyl)phenol; DESETHYL AMODIAQUINE; SCHEMBL14067597; DTXSID20229630; BCP34368; ZINC5139697; BDBM50056190; AKOS025401980; SB73009; AC-27753; HY-128554; CS-0095816; FT-0665940; A933931; 4-(7-Chloro-quinolin-4-ylamino)-2-ethylaminomethyl-phenol; 4-[(7-chloro-4-quinolyl)amino]-2-(ethylaminomethyl)phenol; Phenol, 4-((7-chloro-4-quinolinyl)amino)-2-((ethylamino)methyl)-; N-Desethyl Amodiaquine-d5 Phenol,2-(aminomethyl)-4-[(7-chloro-4-quinolinyl)amino]-
Click to Show/Hide
|
||||
Structure | |||||
Drug Resistance Disease(s) |
Disease(s) with Resistance Information Validated by in-vivo Model for This Drug
(1 diseases)
Astrocytoma [ICD-11: 2F36]
[1]
|
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
Formula |
C18H18ClN3O
|
||||
IsoSMILES |
CCNCC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O
|
||||
InChI |
1S/C18H18ClN3O/c1-2-20-11-12-9-14(4-6-18(12)23)22-16-7-8-21-17-10-13(19)3-5-15(16)17/h3-10,20,23H,2,11H2,1H3,(H,21,22)
|
||||
InChIKey |
VRXFDHAGFYWGHT-UHFFFAOYSA-N
|
||||
PubChem CID |
Type(s) of Resistant Mechanism of This Drug
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Astrocytoma [ICD-11: 2F36]
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Chloroquine resistance transporter (CRT) | [1] | |||
Molecule Alteration | Missense mutation | p.K76T |
||
Resistant Disease | Malaria [ICD-11: 1F45.0] | |||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Plasmodium falciparum strains | 5833 | ||
Experiment for Molecule Alteration |
MIP probes and PCR sequencing assay | |||
Experiment for Drug Resistance |
SYBR Green I detection assay | |||
Mechanism Description | Notably, the PfCRT Lys76Thr substitution was associated with significantly decreased susceptibility to chloroquine, monodesethylamodiaquine, and AQ-13; associations with other aminoquinolines were not conclusive. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.